Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Shedding Light on the Dark Side of Astrocytes Implicates Vimentin, GFAP
11 July 2003. Recent evidence has enhanced the image of astrocytes, suggesting these glial cells are a source for stem cells (see ARF related news story), and that they mop up Aβ (see ARF related news story). But online publications in this week's PNAS and Nature Neuroscience indicate that astrocytes also are a major impediment to axon repair and to the integration of transplanted tissue into the neural circuitry.

Writing in PNAS, M. Gimenez y Ribotta and colleagues from the University of Montpellier, France, report that transgenic mice lacking two key astrocyte genes are much better at repairing severed spinal cords. The genes, coding for two components of astrocytic filaments, glial fibrillary acidic protein (GFAP), and vimentin, appear essential for normal astrocyte movement and function. This implies that astrocytes cannot build the “glial scar”-long known to form a barrier to axonal regeneration-without these two components of their cytoskeleton. It deepens molecular insight into this “other” impairment to repair (the better-understood one being the inhibitory molecules found on the surface of oligodendrocytes).

First author V. Menet and colleagues show that, after spinal cord lesion, the double-knockout mice actually recover function. These animals had only about a third as many mobility problems as did wild-type animals with the same lesion. Furthermore, while both sets of animals exhibited similar locomotor problems immediately after the lesion, wild-type animals continued to decline. whereas double KOs recovered function.

Menet and colleagues observed that, in the wild-type animals, cells testing positive for the astrocyte marker nestin were abundant in the vicinity of the lesion up to five weeks after the injury. Far fewer astrocytes gathered around the lesion in double KOs, and were almost undetectable after five weeks. As for reinnervation, the authors observed little difference between wild-type and single GFAP or vimentin knockouts, but the double knockouts had significantly higher numbers of serotonin-positive fibers, equivalent to 78 percent innervation of the lesion, as opposed to a maximum innervation of about 47 percent in wild-type animals.

In Nature Neuroscience, principal author Dong Feng Chen and colleagues from Schepens Eye Research Institute, Boston; Goteborg University, Sweden; and Asahikawa Medical College, Japan, report that GFAP/vimentin-null mice also fare better when it comes to integrating neuronal grafts.

First author Reiko Kinouchi and colleagues implanted retinal cells from donor mice into the subretinal space of wild-type or double-KO transgenic animals. The authors then followed the fate of the grafted cells, which expressed enhanced green fluorescent protein as a marker. Kinouchi found little integration of graft tissue into wild-type retina, but about four times as many green neurons in double-knockout retinas, primarily in the ganglion cell layer. Furthermore, most of these cells grew neurites, and confocal images of cells stained with antibodies to neuronal markers indicated that the grafted cells projected axons into the nerve layer.

Together, these results extend previous work from the Goteborg group, which showed that GFAP and vimentin were essential for the glial scar.—Tom Fagan.

References:
Menet V, Prieto M, Privat A, Gimenez y Ribotta M. Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc Natl Acad Sci U S A. 2003 Jul 22 ; 100(15):8999-9004. Abstract

Kinouchi R, Takeda M, Yang L, Wilhelmsson U, Lundkvist A, Pekny M, Chen DF. Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin. Nat Neurosci. 2003 Aug ; 6(8):863-8. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad